Novartis AG (NVS)
97.73
+0.46
(+0.47%)
USD |
NYSE |
May 06, 16:00
98.46
+0.73
(+0.75%)
Pre-Market: 08:59
Novartis Asset Impairment Charge (Quarterly)
Asset Impairment Charge (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Asset Impairment Charge (Quarterly) Data
Date | Value |
---|
Asset Impairment Charge Definition
Asset Impairment Charge is a part of the consolidated statement of cash flows, specifically cash flows from operations. Asset impairment charges occur when the market value of a company's asset decreases below its book value. This process is called a writedown.
Asset Impairment Charge (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Asset Impairment Charge (Quarterly) Benchmarks
Roche Holding AG | -- |
Sandoz Group AG | -- |
Amgen Inc | -- |
Incyte Corp | -- |
MorphoSys AG | -- |